%0 Letter
%T Use of trastuzumab and pertuzumab with FOLFOXIRI as neoadjuvant therapy for HER2-positive resectable metastatic colorectal cancer: The first case report.
%A Pang HY
%A Yan MY
%A Chen XF
%A Sun H
%J Asian J Surg
%V 0
%N 0
%D 2024 Jul 24
%M 39048442
%F 2.808
%R 10.1016/j.asjsur.2024.07.136